← Open Payments lookup

SUSAN GIESKE: Open Payments

NPI 1346908407 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,921 in 120 payments from 18 companies in 2025. Trend: 2023 $2,543 · 2024 $2,299 · 2025 $2,921

Food & beverage: $2,921
CompanyPaymentsAmount
ABBVIE INC.31$714
GENZYME CORPORATION6$299
Madrigal Pharmaceuticals8$259
Gilead Sciences, Inc.11$253
Janssen Biotech, Inc.9$213
Takeda Pharmaceuticals U.S.A., Inc.8$211
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$186
QOL Medical, LLC11$176
Ardelyx, Inc.4$131
Regeneron Healthcare Solutions, Inc.4$89

Products named: REZDIFFRA, DUPIXENT, TREMFYA, RINVOQ, XIFAXAN, Sucraid, ENTYVIO, SKYRIZI.

Industry payments across CO — which companies pay providers there.